Opthea raises solvency concerns after phase 3 trial fails
Investing.com--U.S. and Australia-listed biopharmaceutical firm Opthea Ltd (NASDAQ: OPT ) on Monday raised concerns over its ability to continue opera...
Analysis-Australia digs in as top destination for mining listings
By Melanie Burton and Divya Rajagopal MELBOURNE (Reuters) - Australia’s bourse is set for a record number of secondary listings this year from mine developers enticed by the country’...
Genetic testing firm 23andMe files for bankruptcy, seeks asset sale
Investing.com-- 23Andme Holding Co (NASDAQ: ME ) has filed for Chapter 11 bankruptcy in the U.S. Bankruptcy Court for the Eastern District of Missouri to facilitate a court-sup...
